StockGlow

Bristol-Myers Squibb Company (BMYS.VI)

Develops medicines treating cancer, blood disorders, autoimmune diseases, and heart conditions.

55.85-0.00%Healthcare
Compare BMYS.VI with
StockGlow Score
97
Bullish
BearishBullish
1 year ago+47.6%

The outlook

BMYS is trading near its 52-week highs, well above its key moving averages. Analyst coverage appears thin on this data view. The stock's valuation sits at a trailing P/E of 17.8, and current price momentum reflects strength within its recent trading range.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range99% of the way from its 52-week low to high
Market cap
$114.05B
52-wk high
56.08
52-wk low
36.69
50-day avg
50.26
200-day avg
47.74
Trailing P/E
17.8

Similar stocks

BRM.FBristol-Myers Squibb Company$55.66-1.21%PZX.VIPing An Insurance (Group) Company of China, Ltd.$6.47+1.20%BRM.DEBristol-Myers Squibb Company$55.93-0.14%SIE.VISiemens Aktiengesellschaft$269.00-0.98%AXP.VIAmerican Express Company$294.80+0.17%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy